The company plans to make the diagnostic available to physicians and researchers this summer, expanding its portfolio beyond ...

Scientists at The Jackson Laboratory are working on a promising diagnostic tool that could identify Alzheimer’s disease and other forms of dementia decades before symptoms appear.

UNSW Sydney scientists are working to develop Australia's first commercialised lipid-based blood test for breast cancer detection powered by ...

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85% ...

Quest Diagnostics Incorporated (NYSE:DGX) is one of the 7 most undervalued pot stocks to buy according to analysts. On June ...

A national pilot study designed to determine if blood tests can help detect cancers earlier is open for enrollment.Results of ...

Titer tests are what's used "to help you determine if you currently have immunity to certain diseases due to past infection ...

While most people mark their age by the number of birthdays they've celebrated, scientists have long known that the body's organs do not all age at ...

C2N Diagnostics Expands Portfolio of Blood Tests for Clinical Researchers Studying Alzheimer’s Disease and Related Dementias ...

The eye test would be another tool for early diagnosis of degenerative brain diseases. A blood test that assists with early ...

Researchers at the Federal University of São Carlos (UFSCar) in the state of São Paulo, Brazil, are developing a panel of ...

Quest will offer the first FDA-approved blood test to help detect Alzheimer’s-related amyloid pathology in patients with ...